Open AccessA new identified CD20-spliced protein as potential target for T cell-based immunotherapy in B-cell lymphoma/leukemia patients
Author(s) -
Charline Vauchy,
Gamonet Cl�mentine,
Étienne Daguindau,
Carole Henry,
Rohrlich Pierre Simon,
Olivier Adotevi,
Christophe Borg,
Christophe Ferrand,
Godet Yann
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.01196
Subject(s) - cd20 , rituximab , chronic lymphocytic leukemia , lymphoma , immunotherapy , b cell , mantle cell lymphoma , follicular lymphoma , medicine , cancer research , leukemia , immunology , epitope , antigen , biology , antibody , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom